STEPHANIE LEDET: Open Payments
NPI 1376790055 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 13 payments from 9 companies in 2025. Trend: 2023 $810 · 2024 $383 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $159 |
| CVRx, Inc. | 1 | $54 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
| BridgeBio Pharma, Inc. | 1 | $30 |
| United Therapeutics Corporation | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Barostim Neo System, FUROSCIX, Attruby, LEQVIO, ELIQUIS, VERQUVO.
Industry payments across LA — which companies pay providers there.
